デフォルト表紙
市場調査レポート
商品コード
1694472

臨床質量分析の世界市場:市場規模、メーカー、サプライチェーン、販売チャネル、顧客 2025-2031年までの予測

Global Clinical Mass Spectrometry Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031


出版日
発行
QYResearch
ページ情報
英文 136 Pages
納期
2~3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.18円
臨床質量分析の世界市場:市場規模、メーカー、サプライチェーン、販売チャネル、顧客 2025-2031年までの予測
出版日: 2025年04月02日
発行: QYResearch
ページ情報: 英文 136 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、臨床質量分析 (Clinical Mass Spectrometry) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 臨床質量分析の製品概要
  • 市場:タイプ別
    • 世界の臨床質量分析の市場規模成長率:タイプ別 (2020 VS 2024 VS 2031)
    • LC-MS
    • MALDI-TOF MS
    • Other
  • 市場:用途別
    • 世界の臨床質量分析の市場規模成長率:用途別 (2020 VS 2024 VS 2031)
    • Clinical Diagnostics
    • Clinical Research
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の臨床質量分析 市場規模 推定および予測
    • 世界の臨床質量分析 収益 2020-2031
    • 世界の臨床質量分析 売上 2020-2031
  • 臨床質量分析 市場規模:地域別: 2024 VS 2031
  • 臨床質量分析 販売:地域別 (2020-2031)
    • 世界の臨床質量分析 販売:地域別: 2020-2025
    • 世界の臨床質量分析の販売予測:地域別 (2026-2031)
    • 世界の臨床質量分析の販売市場シェア 地域別 (2020-2031)
  • 臨床質量分析の市場 推定および予測:地域別 (2026-2031)
    • 世界の臨床質量分析 収益:地域別: 2020-2025
    • 世界の臨床質量分析の収益予測:地域別 (2026-2031)
    • 世界の臨床質量分析の収益市場シェア 地域別 (2020-2031)

第3章 市場セグメント

  • 内訳データ:タイプ別
    • 世界の臨床質量分析 販売:タイプ別 (2020-2031)
    • 世界の臨床質量分析 収益:タイプ別 (2020-2031)
    • 臨床質量分析 平均 販売価格:タイプ別 (2020-2031)
  • 内訳データ:用途別
    • 世界の臨床質量分析 販売:用途別 (2020-2031)
    • 世界の臨床質量分析 収益:用途別 (2020-2031)
    • 臨床質量分析 平均 販売価格 (ASP) 用途別 (2020-2031)
  • タイプ別および用途別 交差分析
    • LC-MS of Clinical Mass Spectrometry Revenue Market Share by Application
    • MALDI-TOF MS of Clinical Mass Spectrometry Revenue Market Share by Application
    • Other of Clinical Mass Spectrometry Revenue Market Share by Application

第4章 世界の臨床質量分析 :企業別

  • 世界の臨床質量分析の上位企業:販売別 (2020-2025)
    • 世界の臨床質量分析の販売:企業別 (2020-2025)
    • 世界の臨床質量分析の販売市場シェア:企業別 (2020-2025)
  • 世界の臨床質量分析の上位企業:収益別 (2020-2025)
    • 世界の臨床質量分析 収益 メーカー別 (2020-2025)
    • 世界の臨床質量分析 収益 シェア メーカー別 (2020-2025)
  • 世界の臨床質量分析 価格 メーカー別 (2020-2025)
  • 競合状況
    • 臨床質量分析の主要メーカー: 売上高ランキング
    • 世界の臨床質量分析 市場集中度 (CR5 and HHI) & (2020-2025)
    • 世界の臨床質量分析の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の臨床質量分析の製造拠点分布, 製品タイプ
    • Clinical Mass Spectrometry Manufacturers Manufacturing Base Distribution, Headquarters
    • Date of International Manufacturers Enter into Clinical Mass Spectrometry Market
    • Manufacturers Clinical Mass Spectrometry Product Type and Application
    • LC-MS Market Sales of Clinical Mass Spectrometry by Manufacturer
    • MALDI-TOF MS Market Sales of Clinical Mass Spectrometry by Manufacturer
    • Other Market Sales of Clinical Mass Spectrometry by Manufacturer
  • 企業のM&A, 拡張計画

第5章 企業プロファイル

  • Danaher
  • Bruker
  • Agilent
  • Thermo Fisher
  • Waters
  • Shidmazu
  • Perkin Elmer

第6章 北米

  • 北米の臨床質量分析の市場規模:対前年成長率 2020-2031
  • 北米の臨床質量分析の市場概要と数値:国別
    • 北米の臨床質量分析の販売:国別 (2020-2031)
    • 北米の臨床質量分析の収益:国別 (2020-2031)
  • 北米の臨床質量分析 販売:タイプ別 (2020-2025)
  • 北米の臨床質量分析 販売:用途別 (2020-2025)

第7章 アジア太平洋地域

  • アジア太平洋地域 臨床質量分析の市場規模:対前年成長率 2020-2031
  • アジア太平洋地域 臨床質量分析の市場概要と数値:地域別
    • アジア太平洋地域 臨床質量分析 販売:地域別 (2020-2031)
    • アジア太平洋地域 臨床質量分析 収益:地域別 (2020-2031)
  • アジア太平洋地域 臨床質量分析 販売:タイプ別 (2020-2025)
  • アジア太平洋地域 臨床質量分析 販売:用途別 (2020-2025)

第8章 欧州

  • 欧州の臨床質量分析の市場規模:対前年成長率 2020-2031
  • 欧州の臨床質量分析の市場概要と数値:国別
    • 欧州の臨床質量分析の販売:国別 (2020-2031)
    • 欧州の臨床質量分析の収益:国別 (2020-2031)
  • 欧州の臨床質量分析 販売:タイプ別 (2020-2025)
  • 欧州の臨床質量分析 販売:用途別 (2020-2025)

第9章 ラテンアメリカ

  • ラテンアメリカの臨床質量分析の市場規模:対前年成長率 2020-2031
  • ラテンアメリカの臨床質量分析の市場概要と数値:国別
    • ラテンアメリカの臨床質量分析の販売:国別 (2020-2031)
    • ラテンアメリカの臨床質量分析の収益:国別 (2020-2031)
  • ラテンアメリカの臨床質量分析 販売:タイプ別 (2020-2025)
  • ラテンアメリカの臨床質量分析 販売:用途別 (2020-2025)

第10章 中東・アフリカ

  • ラテンアメリカの臨床質量分析の市場規模:対前年成長率 2020-2031
  • 中東・アフリカの臨床質量分析の市場概要と数値:国別
    • 中東・アフリカの臨床質量分析の販売:国別 (2020-2031)
    • 中東・アフリカの臨床質量分析の収益:国別 (2020-2031)
  • 中東・アフリカの臨床質量分析 販売:タイプ別 (2020-2025)
  • 中東・アフリカの臨床質量分析 販売:用途別 (2020-2025)

第11章 サプライチェーンと販売チャネル分析

  • 臨床質量分析 サプライチェーン分析
  • 臨床質量分析 主要原材料 and 上流サプライヤー
  • 臨床質量分析 顧客分析
  • 臨床質量分析 販売チャネル and 販売モデル分析
    • 臨床質量分析 流通チャネル分析: 間接販売 VS 直接販売
    • 臨床質量分析 流通チャネル分析: オンライン販売 VS オフライン販売
    • 臨床質量分析 卸業者

第12章 臨床質量分析 市場動向

  • 臨床質量分析 業界動向
  • 臨床質量分析 市場の促進要因
  • 臨床質量分析 市場の課題
  • 臨床質量分析 市場の抑制要因

第13章 市場調査結果と結論

第14章 付録

図表

List of Tables

Table 1. Global Clinical Mass Spectrometry Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Clinical Mass Spectrometry Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Clinical Mass Spectrometry Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Clinical Mass Spectrometry Sales by Region (2020-2025) & (K Units)

Table 5. Global Clinical Mass Spectrometry Sales Forecast by Region (2026-2031) & (K Units)

Table 6. Global Clinical Mass Spectrometry Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Clinical Mass Spectrometry Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Clinical Mass Spectrometry Sales Volume by Type (2020-2025) & (K Units)

Table 9. Global Clinical Mass Spectrometry Sales Volume by Type (2026-2031) & (K Units)

Table 10. Global Clinical Mass Spectrometry Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Clinical Mass Spectrometry Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Clinical Mass Spectrometry Sales Volume by Application (2020-2025) & (K Units)

Table 13. Global Clinical Mass Spectrometry Sales Volume by Application (2026-2031) & (K Units)

Table 14. Global Clinical Mass Spectrometry Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Clinical Mass Spectrometry Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Clinical Mass Spectrometry Sales by Manufacturer (2020-2025) & (K Units)

Table 17. Global Clinical Mass Spectrometry Sales Share by Manufacturer (2020-2025)

Table 18. Clinical Mass Spectrometry Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Clinical Mass Spectrometry Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Clinical Mass Spectrometry Price (2020-2025) & (USD/Unit)

Table 21. Ranking of Global Top Clinical Mass Spectrometry Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Clinical Mass Spectrometry Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Clinical Mass Spectrometry by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Mass Spectrometry as of 2024)

Table 24. Clinical Mass Spectrometry Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Clinical Mass Spectrometry Market

Table 26. Manufacturers Clinical Mass Spectrometry Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Danaher Company Information

Table 29. Danaher Description and Business Overview

Table 30. Danaher Clinical Mass Spectrometry Product

Table 31. Danaher Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 32. Danaher Sales Proportion of Clinical Mass Spectrometry by Product in 2024

Table 33. Danaher Sales Proportion of Clinical Mass Spectrometry by Application in 2024

Table 34. Danaher Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2024

Table 35. Danaher Recent Developments

Table 36. Bruker Company Information

Table 37. Bruker Description and Business Overview

Table 38. Bruker Clinical Mass Spectrometry Product

Table 39. Bruker Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 40. Bruker Sales Proportion of Clinical Mass Spectrometry by Product in 2024

Table 41. Bruker Sales Proportion of Clinical Mass Spectrometry by Application in 2024

Table 42. Bruker Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2024

Table 43. Bruker Recent Developments

Table 44. Agilent Company Information

Table 45. Agilent Description and Business Overview

Table 46. Agilent Clinical Mass Spectrometry Product

Table 47. Agilent Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 48. Agilent Sales Proportion of Clinical Mass Spectrometry by Product in 2024

Table 49. Agilent Sales Proportion of Clinical Mass Spectrometry by Application in 2024

Table 50. Agilent Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2024

Table 51. Agilent Recent Developments

Table 52. Thermo Fisher Company Information

Table 53. Thermo Fisher Description and Business Overview

Table 54. Thermo Fisher Clinical Mass Spectrometry Product

Table 55. Thermo Fisher Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 56. Thermo Fisher Sales Proportion of Clinical Mass Spectrometry by Product in 2024

Table 57. Thermo Fisher Sales Proportion of Clinical Mass Spectrometry by Application in 2024

Table 58. Thermo Fisher Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2024

Table 59. Thermo Fisher Recent Developments

Table 60. Waters Company Information

Table 61. Waters Description and Business Overview

Table 62. Waters Clinical Mass Spectrometry Product

Table 63. Waters Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 64. Waters Sales Proportion of Clinical Mass Spectrometry by Product in 2024

Table 65. Waters Sales Proportion of Clinical Mass Spectrometry by Application in 2024

Table 66. Waters Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2024

Table 67. Waters Recent Developments

Table 68. Shidmazu Company Information

Table 69. Shidmazu Description and Business Overview

Table 70. Shidmazu Clinical Mass Spectrometry Product

Table 71. Shidmazu Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 72. Shidmazu Sales Proportion of Clinical Mass Spectrometry by Product in 2024

Table 73. Shidmazu Sales Proportion of Clinical Mass Spectrometry by Application in 2024

Table 74. Shidmazu Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2024

Table 75. Shidmazu Recent Developments

Table 76. Perkin Elmer Company Information

Table 77. Perkin Elmer Description and Business Overview

Table 78. Perkin Elmer Clinical Mass Spectrometry Product

Table 79. Perkin Elmer Clinical Mass Spectrometry Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 80. Perkin Elmer Sales Proportion of Clinical Mass Spectrometry by Product in 2024

Table 81. Perkin Elmer Sales Proportion of Clinical Mass Spectrometry by Application in 2024

Table 82. Perkin Elmer Sales Proportion of Clinical Mass Spectrometry by Geographic Area in 2024

Table 83. Perkin Elmer Recent Developments

Table 84. North America Clinical Mass Spectrometry Sales by Country (2020-2025) & (K Units)

Table 85. North America Clinical Mass Spectrometry Sales by Country (2026-2031) & (K Units)

Table 86. North America Clinical Mass Spectrometry Revenue by Country (2020-2025) & (US$ Million)

Table 87. North America Clinical Mass Spectrometry Revenue by Country (2026-2031) & (US$ Million)

Table 88. North America Clinical Mass Spectrometry Sales by Type (2020-2025) & (K Units)

Table 89. North America Clinical Mass Spectrometry Sales by Application (2020-2025) & (K Units)

Table 90. Asia-Pacific Clinical Mass Spectrometry Sales by Region (2020-2025) & (K Units)

Table 91. Asia-Pacific Clinical Mass Spectrometry Sales by Region (2026-2031) & (K Units)

Table 92. Asia-Pacific Clinical Mass Spectrometry Revenue by Region (2020-2025) & (US$ Million)

Table 93. Asia-Pacific Clinical Mass Spectrometry Revenue by Region (2026-2031) & (US$ Million)

Table 94. Asia-Pacific Clinical Mass Spectrometry Sales by Type (2020-2025) & (K Units)

Table 95. Asia-Pacific Clinical Mass Spectrometry Sales by Application (2020-2025) & (K Units)

Table 96. Europe Clinical Mass Spectrometry Sales by Country (2020-2025) & (K Units)

Table 97. Europe Clinical Mass Spectrometry Sales by Country (2026-2031) & (K Units)

Table 98. Europe Clinical Mass Spectrometry Revenue by Country (2020-2025) & (US$ Million)

Table 99. Europe Clinical Mass Spectrometry Revenue by Country (2026-2031) & (US$ Million)

Table 100. Europe Clinical Mass Spectrometry Sales by Type (2020-2025) & (K Units)

Table 101. Europe Clinical Mass Spectrometry Sales by Application (2020-2025) & (K Units)

Table 102. Latin America Clinical Mass Spectrometry Sales by Country (2020-2025) & (K Units)

Table 103. Latin America Clinical Mass Spectrometry Sales by Country (2026-2031) & (K Units)

Table 104. Latin America Clinical Mass Spectrometry Revenue by Country (2020-2025) & (US$ Million)

Table 105. Latin America Clinical Mass Spectrometry Revenue by Country (2026-2031) & (US$ Million)

Table 106. Latin America Clinical Mass Spectrometry Sales by Type (2020-2025) & (K Units)

Table 107. Latin America Clinical Mass Spectrometry Sales by Application (2020-2025) & (K Units)

Table 108. Middle East and Africa Clinical Mass Spectrometry Sales by Country (2020-2025) & (K Units)

Table 109. Middle East and Africa Clinical Mass Spectrometry Sales by Country (2026-2031) & (K Units)

Table 110. Middle East and Africa Clinical Mass Spectrometry Revenue by Country (2020-2025) & (US$ Million)

Table 111. Middle East and Africa Clinical Mass Spectrometry Revenue by Country (2026-2031) & (US$ Million)

Table 112. Middle East and Africa Clinical Mass Spectrometry Sales by Type (2020-2025) & (K Units)

Table 113. Middle East and Africa Clinical Mass Spectrometry Sales by Application (2020-2025) & (K Units)

Table 114. Clinical Mass Spectrometry Key Raw Materials, Industry Status and Trend

Table 115. Clinical Mass Spectrometry Key Raw Materials and Upstream Suppliers

Table 116. Clinical Mass Spectrometry Clients Status and Trend

Table 117. Clinical Mass Spectrometry Typical Clients

Table 118. Clinical Mass Spectrometry Distributors

Table 119. Clinical Mass Spectrometry Market Trends

Table 120. Clinical Mass Spectrometry Market Drivers

Table 121. Clinical Mass Spectrometry Market Challenges

Table 122. Clinical Mass Spectrometry Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Clinical Mass Spectrometry Product Picture

Figure 2. Global Clinical Mass Spectrometry Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Clinical Mass Spectrometry Sales Market Share by Type in 2024 & 2031

Figure 4. LC-MS Product Picture

Figure 5. MALDI-TOF MS Product Picture

Figure 6. Other Product Picture

Figure 7. Global Clinical Mass Spectrometry Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 8. Global Clinical Mass Spectrometry Sales Market Share by Application in 2024 & 2031

Figure 9. Clinical Diagnostics

Figure 10. Clinical Research

Figure 11. Clinical Mass Spectrometry Report Years Considered

Figure 12. Global Clinical Mass Spectrometry Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Clinical Mass Spectrometry Market Size 2020-2031 (US$ Million)

Figure 14. Global Clinical Mass Spectrometry Sales 2020-2031 (K Units)

Figure 15. Global Clinical Mass Spectrometry Sales Market Share Forecast by Region (2020-2031)

Figure 16. Global Clinical Mass Spectrometry Revenue Market Share by Region (2020-2031)

Figure 17. Global Clinical Mass Spectrometry Sales Market Share Forecast by Type (2020-2031)

Figure 18. Global Clinical Mass Spectrometry Revenue Market Share Forecast by Type (2020-2031)

Figure 19. Clinical Mass Spectrometry Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)

Figure 20. Global Clinical Mass Spectrometry Sales Market Share Forecast by Application (2020-2031)

Figure 21. Global Clinical Mass Spectrometry Revenue Market Share Forecast by Application (2020-2031)

Figure 22. Clinical Mass Spectrometry Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)

Figure 23. LC-MS of Clinical Mass Spectrometry Revenue Market Share by Application, 2024 VS 2031

Figure 24. MALDI-TOF MS of Clinical Mass Spectrometry Revenue Market Share by Application, 2024 VS 2031

Figure 25. Other of Clinical Mass Spectrometry Revenue Market Share by Application, 2024 VS 2031

Figure 26. Global Clinical Mass Spectrometry Sales Share by Manufacturer in 2024

Figure 27. Clinical Mass Spectrometry Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 28. LC-MS Market Sales Proportion by Manufacturer in 2024

Figure 29. MALDI-TOF MS Market Sales Proportion by Manufacturer in 2024

Figure 30. Other Market Sales Proportion by Manufacturer in 2024

Figure 31. North America Clinical Mass Spectrometry Revenue 2020-2031 (US$ Million)

Figure 32. North America Clinical Mass Spectrometry Sales Market Share by Type (2020-2025)

Figure 33. North America Clinical Mass Spectrometry Sales Market Share by Application (2020-2025)

Figure 34. Asia-Pacific Clinical Mass Spectrometry Revenue 2020-2031 (US$ Million)

Figure 35. Asia-Pacific Clinical Mass Spectrometry Sales Market Share by Region (2020-2031)

Figure 36. Asia-Pacific Clinical Mass Spectrometry Revenue Market Share by Region (2020-2031)

Figure 37. Asia-Pacific Clinical Mass Spectrometry Sales Market Share by Type (2020-2025)

Figure 38. Asia-Pacific Clinical Mass Spectrometry Sales Market Share by Application (2020-2025)

Figure 39. Europe Clinical Mass Spectrometry Revenue Growth Rate 2020-2031 (US$ Million)

Figure 40. Europe Clinical Mass Spectrometry Sales Market Share by Country (2020-2031)

Figure 41. Europe Clinical Mass Spectrometry Revenue Market Share by Country (2020-2031)

Figure 42. Europe Clinical Mass Spectrometry Sales Market Share by Type (2020-2025)

Figure 43. Europe Clinical Mass Spectrometry Sales Market Share by Application (2020-2025)

Figure 44. Latin America Clinical Mass Spectrometry Revenue Growth Rate 2020-2031 (US$ Million)

Figure 45. Latin America Clinical Mass Spectrometry Sales Market Share by Country (2020-2031)

Figure 46. Latin America Clinical Mass Spectrometry Revenue Market Share by Country (2020-2025)

Figure 47. Latin America Clinical Mass Spectrometry Sales Market Share by Type (2020-2025)

Figure 48. Latin America Clinical Mass Spectrometry Sales Market Share by Application (2020-2025)

Figure 49. Middle East and Africa Clinical Mass Spectrometry Revenue Growth Rate 2020-2031 (US$ Million)

Figure 50. Middle East and Africa Clinical Mass Spectrometry Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Clinical Mass Spectrometry Revenue Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Clinical Mass Spectrometry Sales Market Share by Type (2020-2025)

Figure 53. Middle East and Africa Clinical Mass Spectrometry Sales Market Share by Application (2020-2025)

Figure 54. Clinical Mass Spectrometry Supply Chain (Upstream and Downstream Market)

Figure 55. Global Production Market Share of Clinical Mass Spectrometry Raw Materials by Region in 2024

Figure 56. Clinical Mass Spectrometry Distribution Channels

Figure 57. Global Clinical Mass Spectrometry Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 58. Global Clinical Mass Spectrometry Percentage 2020-2031: Online Sales VS Offline Sales

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

目次

This research report focuses on the Clinical Mass Spectrometry Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Clinical Mass Spectrometry Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Clinical Mass Spectrometry Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
    • 1.2.2 LC-MS
    • 1.2.3 MALDI-TOF MS
    • 1.2.4 Other
  • 1.3 Market by Application
    • 1.3.1 Global Clinical Mass Spectrometry Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
    • 1.3.2 Clinical Diagnostics
    • 1.3.3 Clinical Research
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Clinical Mass Spectrometry Market Size Estimates and Forecasts
    • 2.1.1 Global Clinical Mass Spectrometry Revenue 2020-2031
    • 2.1.2 Global Clinical Mass Spectrometry Sales 2020-2031
  • 2.2 Clinical Mass Spectrometry Market Size by Region: 2024 Versus 2031
  • 2.3 Clinical Mass Spectrometry Sales by Region (2020-2031)
    • 2.3.1 Global Clinical Mass Spectrometry Sales by Region: 2020-2025
    • 2.3.2 Global Clinical Mass Spectrometry Sales Forecast by Region (2026-2031)
    • 2.3.3 Global Clinical Mass Spectrometry Sales Market Share by Region (2020-2031)
  • 2.4 Clinical Mass Spectrometry Market Estimates and Projections by Region (2026-2031)
    • 2.4.1 Global Clinical Mass Spectrometry Revenue by Region: 2020-2025
    • 2.4.2 Global Clinical Mass Spectrometry Revenue Forecast by Region (2026-2031)
    • 2.4.3 Global Clinical Mass Spectrometry Revenue Market Share by Region (2020-2031)

3 Market Segments

  • 3.1 Breakdown Data by Type
    • 3.1.1 Global Clinical Mass Spectrometry Sales by Type (2020-2031)
      • 3.1.1.1 Global Clinical Mass Spectrometry Sales Volume by Type (2020-2031)
      • 3.1.1.2 Global Clinical Mass Spectrometry Sales Market Share by Type (2020-2031)
    • 3.1.2 Global Clinical Mass Spectrometry Revenue by Type (2020-2031)
      • 3.1.2.1 Global Clinical Mass Spectrometry Revenue by Type (2020-2031)
      • 3.1.2.2 Global Clinical Mass Spectrometry Revenue Market Share by Type (2020-2031)
    • 3.1.3 Clinical Mass Spectrometry Average Selling Price (ASP) by Type (2020-2031)
  • 3.2 Breakdown Data by Application
    • 3.2.1 Global Clinical Mass Spectrometry Sales by Application (2020-2031)
      • 3.2.1.1 Global Clinical Mass Spectrometry Sales Volume by Application (2020-2031)
      • 3.2.1.2 Global Clinical Mass Spectrometry Sales Market Share by Application (2020-2031)
    • 3.2.2 Global Clinical Mass Spectrometry Revenue by Application (2020-2031)
      • 3.2.2.1 Global Clinical Mass Spectrometry Revenue by Application (2020-2031)
      • 3.2.2.2 Global Clinical Mass Spectrometry Revenue Market Share by Application (2020-2031)
    • 3.2.3 Clinical Mass Spectrometry Average Selling Price (ASP) by Application (2020-2031)
  • 3.3 by Type and by Application Crossing Analysis
    • 3.3.1 LC-MS of Clinical Mass Spectrometry Revenue Market Share by Application
    • 3.3.2 MALDI-TOF MS of Clinical Mass Spectrometry Revenue Market Share by Application
    • 3.3.3 Other of Clinical Mass Spectrometry Revenue Market Share by Application

4 Global Clinical Mass Spectrometry by Manufacturers

  • 4.1 Global Top Clinical Mass Spectrometry Manufacturers by Sales (2020-2025)
    • 4.1.1 Global Clinical Mass Spectrometry Sales by Manufacturer (2020-2025)
    • 4.1.2 Global Clinical Mass Spectrometry Sales Market Share by Manufacturer (2020-2025)
  • 4.2 Global Top Clinical Mass Spectrometry Manufacturers by Revenue (2020-2025)
    • 4.2.1 Global Clinical Mass Spectrometry Revenue by Manufacturer (2020-2025)
    • 4.2.2 Global Clinical Mass Spectrometry Revenue Share by Manufacturer (2020-2025)
  • 4.3 Global Clinical Mass Spectrometry Price by Manufacturer (2020-2025)
  • 4.4 Competitive Landscape
    • 4.4.1 Key Clinical Mass Spectrometry Manufacturers Covered: Ranking by Revenue
    • 4.4.2 Global Clinical Mass Spectrometry Market Concentration Ratio (CR5 and HHI) & (2020-2025)
    • 4.4.3 Global Clinical Mass Spectrometry Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.5 Global Clinical Mass Spectrometry Manufacturing Base Distribution, Product Type
    • 4.5.1 Clinical Mass Spectrometry Manufacturers Manufacturing Base Distribution, Headquarters
    • 4.5.2 Date of International Manufacturers Enter into Clinical Mass Spectrometry Market
    • 4.5.3 Manufacturers Clinical Mass Spectrometry Product Type and Application
    • 4.5.4 LC-MS Market Sales of Clinical Mass Spectrometry by Manufacturer
    • 4.5.5 MALDI-TOF MS Market Sales of Clinical Mass Spectrometry by Manufacturer
    • 4.5.6 Other Market Sales of Clinical Mass Spectrometry by Manufacturer
  • 4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

  • 5.1 Danaher
    • 5.1.1 Danaher Company Information
    • 5.1.2 Danaher Description, Business Overview
    • 5.1.3 Danaher Clinical Mass Spectrometry Products Offered
    • 5.1.4 Danaher Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2020-2025)
    • 5.1.5 Danaher Clinical Mass Spectrometry Sales by Product in 2024
    • 5.1.6 Danaher Clinical Mass Spectrometry Sales by Application in 2024
    • 5.1.7 Danaher Clinical Mass Spectrometry Sales by Geographic Area in 2024
    • 5.1.8 Danaher Recent Developments
  • 5.2 Bruker
    • 5.2.1 Bruker Company Information
    • 5.2.2 Bruker Description, Business Overview
    • 5.2.3 Bruker Clinical Mass Spectrometry Products Offered
    • 5.2.4 Bruker Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2020-2025)
    • 5.2.5 Bruker Clinical Mass Spectrometry Sales by Product in 2024
    • 5.2.6 Bruker Clinical Mass Spectrometry Sales by Application in 2024
    • 5.2.7 Bruker Clinical Mass Spectrometry Sales by Geographic Area in 2024
    • 5.2.8 Bruker Recent Developments
  • 5.3 Agilent
    • 5.3.1 Agilent Company Information
    • 5.3.2 Agilent Description, Business Overview
    • 5.3.3 Agilent Clinical Mass Spectrometry Products Offered
    • 5.3.4 Agilent Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2020-2025)
    • 5.3.5 Agilent Clinical Mass Spectrometry Sales by Product in 2024
    • 5.3.6 Agilent Clinical Mass Spectrometry Sales by Application in 2024
    • 5.3.7 Agilent Clinical Mass Spectrometry Sales by Geographic Area in 2024
    • 5.3.8 Agilent Recent Developments
  • 5.4 Thermo Fisher
    • 5.4.1 Thermo Fisher Company Information
    • 5.4.2 Thermo Fisher Description, Business Overview
    • 5.4.3 Thermo Fisher Clinical Mass Spectrometry Products Offered
    • 5.4.4 Thermo Fisher Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2020-2025)
    • 5.4.5 Thermo Fisher Clinical Mass Spectrometry Sales by Product in 2024
    • 5.4.6 Thermo Fisher Clinical Mass Spectrometry Sales by Application in 2024
    • 5.4.7 Thermo Fisher Clinical Mass Spectrometry Sales by Geographic Area in 2024
    • 5.4.8 Thermo Fisher Recent Developments
  • 5.5 Waters
    • 5.5.1 Waters Company Information
    • 5.5.2 Waters Description, Business Overview
    • 5.5.3 Waters Clinical Mass Spectrometry Products Offered
    • 5.5.4 Waters Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2020-2025)
    • 5.5.5 Waters Clinical Mass Spectrometry Sales by Product in 2024
    • 5.5.6 Waters Clinical Mass Spectrometry Sales by Application in 2024
    • 5.5.7 Waters Clinical Mass Spectrometry Sales by Geographic Area in 2024
    • 5.5.8 Waters Recent Developments
  • 5.6 Shidmazu
    • 5.6.1 Shidmazu Company Information
    • 5.6.2 Shidmazu Description, Business Overview
    • 5.6.3 Shidmazu Clinical Mass Spectrometry Products Offered
    • 5.6.4 Shidmazu Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2020-2025)
    • 5.6.5 Shidmazu Clinical Mass Spectrometry Sales by Product in 2024
    • 5.6.6 Shidmazu Clinical Mass Spectrometry Sales by Application in 2024
    • 5.6.7 Shidmazu Clinical Mass Spectrometry Sales by Geographic Area in 2024
    • 5.6.8 Shidmazu Recent Developments
  • 5.7 Perkin Elmer
    • 5.7.1 Perkin Elmer Company Information
    • 5.7.2 Perkin Elmer Description, Business Overview
    • 5.7.3 Perkin Elmer Clinical Mass Spectrometry Products Offered
    • 5.7.4 Perkin Elmer Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2020-2025)
    • 5.7.5 Perkin Elmer Clinical Mass Spectrometry Sales by Product in 2024
    • 5.7.6 Perkin Elmer Clinical Mass Spectrometry Sales by Application in 2024
    • 5.7.7 Perkin Elmer Clinical Mass Spectrometry Sales by Geographic Area in 2024
    • 5.7.8 Perkin Elmer Recent Developments

6 North America

  • 6.1 North America Clinical Mass Spectrometry Market Size YoY Growth 2020-2031
  • 6.2 North America Clinical Mass Spectrometry Market Facts & Figures by Country
    • 6.2.1 North America Clinical Mass Spectrometry Sales by Country (2020-2031)
    • 6.2.2 North America Clinical Mass Spectrometry Revenue by Country (2020-2031)
  • 6.3 North America Clinical Mass Spectrometry Sales by Type (2020-2025)
  • 6.4 North America Clinical Mass Spectrometry Sales by Application (2020-2025)

7 Asia-Pacific

  • 7.1 Asia-Pacific Clinical Mass Spectrometry Market Size YoY Growth 2020-2031
  • 7.2 Asia-Pacific Clinical Mass Spectrometry Market Facts & Figures by Region
    • 7.2.1 Asia-Pacific Clinical Mass Spectrometry Sales by Region (2020-2031)
    • 7.2.2 Asia-Pacific Clinical Mass Spectrometry Revenue by Region (2020-2031)
  • 7.3 Asia-Pacific Clinical Mass Spectrometry Sales by Type (2020-2025)
  • 7.4 Asia-Pacific Clinical Mass Spectrometry Sales by Application (2020-2025)

8 Europe

  • 8.1 Europe Clinical Mass Spectrometry Market Size YoY Growth 2020-2031
  • 8.2 Europe Clinical Mass Spectrometry Market Facts & Figures by Country
    • 8.2.1 Europe Clinical Mass Spectrometry Sales by Country (2020-2031)
    • 8.2.2 Europe Clinical Mass Spectrometry Revenue by Country (2020-2031)
  • 8.3 Europe Clinical Mass Spectrometry Sales by Type (2020-2025)
  • 8.4 Europe Clinical Mass Spectrometry Sales by Application (2020-2025)

9 Latin America

  • 9.1 Latin America Clinical Mass Spectrometry Market Size YoY Growth 2020-2031
  • 9.2 Latin America Clinical Mass Spectrometry Market Facts & Figures by Country
    • 9.2.1 Latin America Clinical Mass Spectrometry Sales by Country (2020-2031)
    • 9.2.2 Latin America Clinical Mass Spectrometry Revenue by Country (2020-2031)
  • 9.3 Latin America Clinical Mass Spectrometry Sales by Type (2020-2025)
  • 9.4 Latin America Clinical Mass Spectrometry Sales by Application (2020-2025)

10 Middle East and Africa

  • 10.1 Latin America Clinical Mass Spectrometry Market Size YoY Growth 2020-2031
  • 10.2 Middle East and Africa Clinical Mass Spectrometry Market Facts & Figures by Country
    • 10.2.1 Middle East and Africa Clinical Mass Spectrometry Sales by Country (2020-2031)
    • 10.2.2 Middle East and Africa Clinical Mass Spectrometry Revenue by Country (2020-2031)
  • 10.3 Middle East and Africa Clinical Mass Spectrometry Sales by Type (2020-2025)
  • 10.4 Middle East and Africa Clinical Mass Spectrometry Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

  • 11.1 Clinical Mass Spectrometry Supply Chain Analysis
  • 11.2 Clinical Mass Spectrometry Key Raw Materials and Upstream Suppliers
  • 11.3 Clinical Mass Spectrometry Clients Analysis
  • 11.4 Clinical Mass Spectrometry Sales Channel and Sales Model Analysis
    • 11.4.1 Clinical Mass Spectrometry Distribution Channel Analysis: Indirect Sales VS Direct Sales
    • 11.4.2 Clinical Mass Spectrometry Distribution Channel Analysis: Online Sales VS Offline Sales
    • 11.4.3 Clinical Mass Spectrometry Distributors

12 Clinical Mass Spectrometry Market Dynamics

  • 12.1 Clinical Mass Spectrometry Industry Trends
  • 12.2 Clinical Mass Spectrometry Market Drivers
  • 12.3 Clinical Mass Spectrometry Market Challenges
  • 12.4 Clinical Mass Spectrometry Market Restraints

13 Research Findings and Conclusion

14 Appendix

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
      • 14.1.1.1 Research Programs/Design
      • 14.1.1.2 Market Size Estimation
      • 14.1.1.3 Market Breakdown and Data Triangulation
    • 14.1.2 Data Source
      • 14.1.2.1 Secondary Sources
      • 14.1.2.2 Primary Sources
  • 14.2 Author Details
  • 14.3 Disclaimer